European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 5.07
+0.32 (6.70%)
Jan 20, 2026, 9:33 AM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €21.45 million as of January 20, 2026. Its market cap has decreased by -23.77% in one year.
Market Cap
21.45M
Enterprise Value
37.88M
Revenue
49.47M
Ranking
n/a
PE Ratio
18.29
Stock Price
€5.07
Market Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 21.45M, a decrease of -75.08%. That is a compound annual growth rate of -13.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 21.45M | -2.52% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 49.00B |
| argenx SE | 41.97B |
| Financière de Tubize | 10.04B |
| Hyloris Pharmaceuticals | 212.80M |
| Onward Medical | 197.06M |
| Celyad Oncology | 7.92M |
| BioSenic | 1.63M |
| Oxurion NV | 413.15K |